ArticleBulletin of the World Health Organization2021
Global access to affordable direct oral anticoagulants.
Article in Bulletin of the World Health Organization, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 17 citations in OpenAlex.
- Penetrating Chest Trauma With Lung Evisceration, Pneumomediastinum, Pneumocranium, and Brachial Plexus Injury: A Case Report From a Resource-Limited Setting.Clinical case reports · 2026Article
- Medical haematology: Repositioning haematology at the centre of medicine.British journal of haematology · 2026Review
- Healthcare in the United States: politics, policy, and potential global impact.Journal of thrombosis and thrombolysis · 2026Article
- Deep vein thrombosis as a public health priority: wHO's agenda for Africa 2030.Frontiers in cardiovascular medicine · 2026Review
- Next-Generation Anticoagulants: Precision Strategies for Patient-Centered Thromboprophylaxis.Journal of personalized medicine · 2025Review
- Availability, pricing, and affordability of antithrombotic medicines in Addis Ababa, Ethiopia: implications for health policy.Journal of pharmaceutical health care and sciences · 2025Article
- A Saudi Heart Association Position Statement on the use of DOACs in Patients With Arterial and Venous Thrombosis.Journal of the Saudi Heart Association · 2025Article
- Controlling Prescribing through "Preferred Drug" Targets-The Bavarian Experience.International journal of environmental research and public health · 2024Article
- Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand.Applied health economics and health policy · 2024Article
- Ethnic Diversity and Warfarin Pharmacogenomics.Frontiers in pharmacology · 2022Review
- Characteristics of warfarin under-prescription in older adults with atrial fibrillation.International journal of cardiology. Heart & vasculature · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 3 countries.
Funding
Abstract
Poor control of cardiovascular disease accounts for a substantial proportion of the disease burden in developing countries, but often essential anticoagulant medicines for preventing strokes and embolisms are not widely available. In 2019, direct oral anticoagulants were added to the World Health Organization's
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.